LIMBER UniLeg Prosthesis for Leg Amputation
Trial Summary
What is the purpose of this trial?
The LIMBER UniLeg, a 3D printed single-piece transtibial prosthetic limb, is sufficiently equivalent to traditional passive prosthetic limbs (no motors or sensors), while reducing the cost and time of manufacturing and enabling global reach through the use of digital technologies to solve the worldwide prosthetic accessibility crisis. This is a single-site, Phase I, Clinical Research Study to test the effectiveness and safety of the LIMBER UniLeg. One study group of 30 participants involved for two months using a non-inferiority design in which the participant will be assessed using their normal device (1 month) and the study device (1 month).
Will I have to stop taking my current medications?
The trial protocol does not specify whether you need to stop taking your current medications. However, since the study focuses on prosthetic devices, it seems unlikely that medication changes are required.
What data supports the effectiveness of the LIMBER UniLeg Prosthesis treatment for leg amputation?
The research highlights the importance of a well-fitting and properly aligned prosthesis for comfort and mobility, which are key factors in the effectiveness of prosthetic treatments like the LIMBER UniLeg. Adaptive prosthetics, which include features like lightweight and flexible designs, can significantly improve the quality of life for amputees by allowing them to engage in activities they enjoy.12345
How does the LIMBER UniLeg Prosthesis differ from other treatments for leg amputation?
The LIMBER UniLeg Prosthesis is unique because it is designed to provide a more natural and comfortable fit for individuals with leg amputations, potentially improving mobility and quality of life. Unlike other prostheses, it may incorporate advanced materials or design features that enhance its functionality and adaptability to the user's needs.16789
Research Team
Herb Barrack, CPO
Principal Investigator
LIMBER Prosthetics & Orthotics Inc
Eligibility Criteria
This trial is for individuals with below-the-knee amputations who currently use a passive prosthetic leg. Participants will be involved in the study for two months and must be willing to switch between their normal device and the study device.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Baseline Assessment
Participants are assessed using their normal prosthetic device to establish baseline measurements
Treatment
Participants use the LIMBER UniLeg prosthetic device and are assessed for functionality and safety
Follow-up
Participants are monitored for safety and effectiveness after using the study device
Treatment Details
Interventions
- LIMBER UniLeg
LIMBER UniLeg is already approved in United States for the following indications:
- Transtibial amputation
- Lower limb amputation
Find a Clinic Near You
Who Is Running the Clinical Trial?
LIMBER Prosthetics & Orthotics Inc
Lead Sponsor
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Collaborator
University of California, San Diego
Collaborator